Superworth

Armata Pharmaceuticals EPS ARMP

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$7.59
Latest quarter, Q2 FY26
−$0.27
Fiscal year 2025
−$4.81

Armata Pharmaceuticals' earnings per share was −$7.59 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.27.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$4.81n/a
FY2024−$1.05n/a
FY2023−$1.98n/a
FY2022−$1.09n/a
FY2021−$0.97n/a
FY2020−$1.42n/a
FY2019−$2.70n/a
FY2018−$6.74n/a
FY2017−$52.36n/a
FY2016−$367.92n/a
FY2015−$652.40n/a
FY2014−$715.40n/a
FY2013−$4760.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.27n/a−$7.59
Q1 FY26−$3.16n/a−$7.77
Q4 FY25−$3.42−8650%−$4.81
Q3 FY25−$0.74n/a−$1.35
Q2 FY25−$0.45n/a−$0.76
Q1 FY25−$0.20n/a−$0.56
Q4 FY24$0.04n/a−$1.05
Q3 FY24−$0.15n/a−$1.64
Q2 FY24−$0.25n/a−$2.35
Q1 FY24−$0.69n/a−$2.27
Q4 FY23−$0.55n/a−$1.98
Q3 FY23−$0.86n/a−$1.72

Against its peers

Companies in Healthcare nearest Armata Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
ARMPArmata Pharmaceuticals−$7.59
KEQUKewaunee Scientific$2.76−33% a year
ICCCImmucell$0.08−58% a year
PDEXPro DEX$4.11+52% a year
PLXProtalix BioTherapeutics$0.23+283% a year
NATRNatures Sunshine Products$1.01+36% a year
ELMDElectromed$1.31+56% a year
UTMDUtah Medical Products$3.28−12% a year
LFVNLifevantage$0.40−46% a year
INFUInfuSystem$0.41+78% a year
SPROSpero Therapeutics$0.11
Peer median$0.71

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Armata Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.